Aurora Cannabis reports FQ3 results

May 12, 2022 4:20 PM ETAurora Cannabis Inc. (ACB), ACB:CABy: Niloofer Shaikh, SA News Editor1 Comment
  • Aurora Cannabis press release (NASDAQ:ACB): FQ3 Adjusted EBITDA loss declined to C$12.3M vs. C$9M in Q2 2022 but narrowed from C$20.9M in the prior year period.
  • Revenue of C$50.43M (-8.6% Y/Y).
  • Medical cannabis net revenue up 8% Y/Y to C$39.4M.
  • Management now expects C$150M to C$170M in annualized cost savings by H1/2023 vs. stated target of C$60M to C$80M.
  • Reiterating Adjusted EBITDA profitability run rate by the end of Fiscal H12023.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.